Sexual dysfunction in patients with psoriasis

Stănescu, Ana Maria Alexandra; Grăjdeanu, Ioana Veronica; Șerban, Bogdan; Bratu, Ovidiu Gabriel; Socea, Bogdan; Diaconu, Camelia Cristina

doi:10.31688/abmu.2019.54.2.19

Cited by 3 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hypoestrogenic status has a negative impact on diff erent aspects of female health, not just in menopausal women but also in younger ones [3][4][5] . Normal estrogen levels and metabolic homeostasis have a major importance for the cardiovascular system, normal bone metabolism and mental health, especially in younger women [10][11][12][13][14] . Th erefore, prolonged hypoestrogenism that occurs in young women may have critical signifi cance in the years to come.…”

Section: Discussionmentioning

confidence: 99%

Functional Amenorrhea and Pituitary Microadenoma

Păduraru¹,

ENE²,

Morar³

et al. 2019

Rev. Med. Mod.

Self Cite

View full text Add to dashboard Cite

Introduction: Functional hypothalamic amenorrhea is a diagnostic challenge, especially in association with structural pituitary changes. We present the case of a patient with functional amenorrhea and pituitary microadenoma, evaluated in multiple medical centres. Case report: A 27-year-old female was referred to our clinic for secondary amenorrhea installed 18 months prior, insomnia, polydipsia (around 4-6 l water intake/day) and polyuria. Clinical examination revealed an underweight patient, with BMI (Body Mass Index) of 17.5 kg/m 2 , normal secondary sex characteristics, pallor of the skin and mucosa. The hormonal profi le revealed normal FSH (Follicle Stimulating Hormone) levels, low LH-Luteinizing Hormone (of 0.15 U/L, normal: 1.20-12.8 U/L), estradiol (of 11.2 pg/mL, normal: 49-291 pg/mL) and progesterone (of 1.13 ng/mL, normal: 5.16-18.56 ng/mL). No pathological changes were recorded at somatotropic, lactotropic, thyrotropic and corticotropic levels. The Diphereline stimulation test revealed functional integrity of the pituitary gland and ovaries. The progesterone with drawal test was negative. There were no pathological fi ndings on biochemical workup and the water deprivation test excluded diabetes insipidus. Morphological exploration of the hypothalamic-pituitary region by contrast-enhanced MRI (Magnetic Resonance Imaging) scan revealed a left pituitary microadenoma measuring 5 mm in diameter. Adequate diet and oral contraceptive treatment were recommended. Conclusion: Functional hypothalamic amenorrhea (FHA) is the most common cause of neuroendocrine amenorrhea. Identifying the context and causative factors is essential for making an appropriate therapeutic decision.

show abstract

Section: Discussionmentioning

confidence: 99%

Functional Amenorrhea and Pituitary Microadenoma

Păduraru¹,

ENE²,

Morar³

et al. 2019

Rev. Med. Mod.

Self Cite

View full text Add to dashboard Cite

show abstract

“…Local intravaginal therapy with estriol has been shown to be effective in treating postmenopausal SUI, urogenital atrophy, and recurrent lower urinary tract infections, especially when combined with exercises aimed at improving the muscle tone of the floor. However, the effects are not for long-term [42,43].…”

Section: Management Of Stress Urinary Incontinence In Obese Womenmentioning

confidence: 93%

Obesity and its Implications on Stress Urinary Incontinence

Dumitrașcu¹,

Stănescu²,

Bejan³

et al. 2019

Rev. Chim.

View full text Add to dashboard Cite

Obesity has reached alarming levels worldwide. Urinary incontinence disorders are associated with a profound negative effect on the quality of life. Obesity in women is associated with stress urinary incontinence. This review aims to highlight the mechanisms, the implications, as well as the best therapeutic approach for stress urinary incontinence in obese women, all following the rigorous documentation of the current research.

show abstract